Kite, a Gilead Sciences company, recently reported new analysis showing that its CAR T therapy Yescarta delivers consistent ...

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

By shutting South Africa out of its overseas funding for the roll-out of the revolutionary six-monthly HIV prevention jab which could potentially end Aids, the Trump administration undercuts its own ...

Carlton V. Bell II won second place in GLAAD + STARZ TV Pilot Pitch Competition with a series that will destigmatize HIV.

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best pharma stocks to invest in. Cantor Fitzgerald analyst Carter Gould ...

Finding the best blue-chip stocks to buy is never a simple task, especially when markets are shifting. Economic uncertainty, changing interest-rate expectations and the rapid evolution of ...

ACCRA/GENEVA, 10 December 2025 —African leaders can put the continent back on track to end AIDS by 2030 by choosing to ...

An updated Canadian guideline on HIV prevention addresses the expanding range of medications available to reduce the risk of ...

Viver Health is proud to announce the introduction of Your Guide to Managing Symptoms from Metastatic Breast Cancer Treatment, a take-home, evidence-based educational resource designed to help ...

Malawi on Thursday, December 4, authorised the use of the injectable HIV prevention drug lenacapavir, becoming the fourth ...

According to DataM Intelligence, the HIV Therapeutics Market Size grew to USD 37.61 billion in 2024 and is projected to reach USD 57.56 billion by 2033, advancing at a CAGR of 4.8% during the forecast ...

Citi Annual Global Healthcare Conference 2025 December 2, 2025 11:15 AM ESTCompany ParticipantsAndrew Dickinson - ...